Collegium Pharmaceutical Inc (NASDAQ:COLL)

21.10
Delayed Data
As of Oct 22
 +0.05 / +0.24%
Today’s Change
17.24
Today|||52-Week Range
26.91
+5.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-27.3M-94.2M-74.9M-39.1M
 
 
 
 
 
Depreciation171.0K655.0K594.0K110.9M
 
 
 
 
 
Total Other Cash Flow2.2M5.8M9.8M33.1M
 
 
 
 
 
Funds From Operations-24.9M-87.8M-64.5M104.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.3M-12.7M2.5M-64.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-21.6M-75.1M-67.0M169.4M
 
 
 
 
 
 
InvestingCapital Expenditures-362.0K-477.0K-990.0K-5.5M
 
 
 
 
 
Net Cash Flow Investing-362.0K-3.0M-990.0K-24.4M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings0.000.000.0010.0M
 
 
Long Term Debt Reduction-1.3M-2.7M-2.7M0.00
 
 
 
 
Net Proceeds Stock Sale117.4M138.2M36.2M5.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--0.000.000.00--
Other Uses - Financing16.0K0.0068.0K132.6M
 
 
 
 
Net Cash Flow - Financing116.0M135.6M33.5M-117.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash94.1M57.5M-34.5M27.8M